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Direct targeting of hippocampal neurons for apoptosis by
glucocorticoids is reversible by mineralocorticoid
receptor activation
C Crochemore1,4, J Lu1,4, Y Wu1,4, Zs Liposits2, N Sousa3, F Holsboer1 and OFX Almeida1
1Max Planck Institute of Psychiatry, Munich, Germany; 2Department of Endocrine Neurobiology, Institute of Experimental
Medicine, Hungarian Academy of Sciences, Budapest, Hungary; 3Life and Health Science Research Institute, University of
Minho School of Health Sciences, Braga, Portugal
An important question arising from previous observations in vivo is whether glucocorticoids
can directly influence neuronal survival in the hippocampus. To this end, a primary postnatal
hippocampal culture system containing mature neurons and expressing both glucocorticoid
(GR) and mineralocorticoid (MR) receptors was developed. Results show that the GR agonist
dexamethasone (DEX) targets neurons (microtubule-associated protein 2-positive cells) for
death through apoptosis. GR-mediated cell death was counteracted by the MR agonist
aldosterone (ALDO). Antagonism of MR with spironolactone ([7a-(acetylthio)-3-oxo-17a-pregn-
4-ene,21 carbolactone] (SPIRO)) causes a dose-dependent increase in neuronal apoptosis in
the absence of DEX, indicating that nanomolar levels of corticosterone present in the culture
medium, which are sufficient to activate MR, can mask the apoptotic response to DEX. Indeed,
both SPIRO and another MR antagonist, oxprenoate potassium ((7a,17a)-17-Hydroxy-3-oxo-7-
propylpregn-4-ene-21-carboxylic acid, potassium salt (RU28318)), accentuated DEX-induced
apoptosis. These results demonstrate that GRs can act directly to induce hippocampal
neuronal death and that demonstration of their full apoptotic potency depends on abolition of
survival-promoting actions mediated by MR.
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Disorders of mood and cognition are linked to
hypersecretion of glucocorticoids (GCs) resulting
from reduced efficacy of GC-negative feedback.1–3
One enduring view is that a loss of neurons bearing
glucocorticoid (GR) and mineralocorticoid (MR) re-
ceptors in the hippocampus is the primary cause of
disinhibited hypothalamo-pituiatry-adrenal (HPA) ac-
tivity; moreover, hippocampal cell loss is likely to
have repercussions on cognition and the regulation of
mood and anxiety.
Numerous previous experiments suggest that ex-
cessive corticosteroid secretion endangers the survi-
val of hippocampal neurons by increasing their
vulnerability to concomitant stimuli such as excita-
tory amino acids, calcium influxes and reactive
oxygen species.4,5 The detrimental effects of corticos-
teroids on the hippocampus are backed by imaging
studies in humans: there is a strong negative correla-
tion between cortisol levels and hippocampal volume
in patients with major depression6,7 and in subjects
with Cushing’s disease;8 reduced hippocampal vo-
lumes were also recently found in rats treated with
dexamethasone (DEX), a GR agonist.9 While most of
the hippocampal shrinkage observed may be due to
neuritic atrophy, including dendritic impoverishment
and synaptic loss,10–12 other experiments have de-
monstrated that GR activation activates a molecular
cascade, leading to significant levels of neuronal cell
death through apoptotic mechanisms.13 Besides apop-
tosis of mature hippocampal neurons,14 there is also
evidence that GRs interfere with proliferation of
granule neurons of the dentate gyrus.15
MR and GR both bind cortisol/corticosterone, albeit
with differing affinities: whereas GR become occu-
pied by corticosteroid levels in the high physiological
range, MR appear to be tonically active under basal
levels of HPA activity, and there is evidence that
activity of the two receptors is coordinated so as to
maintain endocrinological and behavioral bal-
ance.1,16,17 We previously proposed that the relative
occupation of MR and GR also contributes to main-
tenance of hippocampal cell numbers, since activa-
tion of MR counteract deleterious GC actions on
neuronal survival.11,13,14 Indeed, the results of earlier
studies suggest that MR occupation may be essential
for the survival of dentate granule neurons.18–20
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The interpretation of previous data showing that
DEX can induce neuronal cell death in animals has
been questioned on the basis that because DEX poorly
penetrates the brain and produces ‘chemical adrena-
lectomy’ by suppressing pituitary ACTH secretion,
the observed cell loss may reflect abolition of MR
activation rather than a direct effect of GR activation.1
The work reported here readdresses this issue by
using a pharmacologically malleable model, namely
primary hippocampal cell cultures. Our results
demonstrate the inherent apoptosis-inducing proper-
ties of DEX, which become better evident if neuro-
protective actions mediated by MR are blocked.
Materials and methods
Experiments on animals were conducted in accor-
dance with the European Communities Council
Directive No. 86/609/EEC and local regulations.
Hippocampal tissue was obtained from male rat pups,
aged 4–5 days (Wistar rats; Charles River, Sulzfeld,
Germany). Pilot in vivo studies in rats of this age
showed an acute injection of DEX (100mg/kg, i.p.) to
result in a 60% increase in apoptotic cells in the
hippocampus (measured by TUNEL histochemistry)
within 24 h.
Tissue and cell dissociation
Rat pups were rapidly decapitated, their brains
carefully dissected out and placed in ice-cold Neuro-
basal/B27 solution (Invitrogen, Karlsruhe, Germany).
Hippocampi were dissected out and freed from
meninges and vascular tissue excess under a dissect-
ing microscope, before being sliced (ca. 250mm thick)
on a McIlwain tissue-chopper. Slices were briefly
washed in ice-cold Neurobasal/B27 medium, centri-
fuged briefly (70 g; 201C) and resuspended in a
solution containing papain; to this end, the Papain
Dissociation Kit (Worthington Biochemical Corp.,
Freehold, NJ, USA) was used with some minor
modifications to the manufacturer’s suggested proto-
col (see Hellbach et al21). Tissue digests were
triturated gently and transferred to a medium con-
sisting of Neurobasal/B27 medium, 1% fetal calf
serum and 0.2% bovine serum albumin (BSA) at
371C, filtered through a sterile nylon mesh (30 mm
pore size) and centrifuged at 200 g (201C; 5 min)
before resuspension in Neurobasal/B27 medium con-
taining enzyme inhibitor (ovomucoid/0.005%
DNAse; Worthington). Aliquots of this suspension
were run through a one-step ovomucoid/BSA density
gradient (centrifugation at 70 g at 201C for 5 min),
taken up in Neurobasal/B27 medium containing basic
fibroblast growth factor (bFGF) (10 ng/ml), Glutamax I
(0.5 mM) and kanamycin (100mg/ml) (all from Invi-
trogen), and plated onto gelatin/PDL-coated glass
coverslips (Superior, Bad Mergentheim, Germany) at
a density of 450733 cells/mm2. Cultures were
maintained at 371C, under 5% CO2 and 99% relative
humidity. Cortisol levels in the B27 supplement
added to the incubation medium were 15–30 ng/ml,
as determined by radioimmunoassay.
Treatments
Cells were exposed to drugs after 6 days in vitro;
exposure to experimental drugs was for 48 h. The GR
agonist (DEX) was obtained as a sodium phosphate
salt in aqueous form (Fortecortins, Merk, Darmstadt,
Germany) and used at doses of either 106 or 105 M.
The prototypic MR agonist aldosterone (ALDO) was
purchased from Sigma (Deisenhofen, Germany) and
used at a dose of 105 M (survival studies) or 108 M
(translocation experiments) after solution in ethanol.
Two MR antagonists were used alone or as cotreat-
ments with DEX: spironolactone ([7a-(acetylthio)-3-
oxo-17a-pregn-4-ene,21 carbolactone] (SPIRO); Sig-
ma) was used at between 109 and 105 M after
solution in ethanol; oxprenoate potassium ((7a,17a)-
17-Hydroxy-3-oxo-7-propylpregn-4-ene-21-carboxylic
acid, potassium salt (RU28318)), purchased from
Tocris Cookson (Bristol, UK), was used at dose
ranging from 109 to 105 M after direct solution in
growing medium. Final ethanol concentrations in the
medium were 0.01%; drug-naive cultures were
incubated in Neurobasal/B27 medium containing
0.01% ethanol for equivalent times. In all experi-
ments, the position of wells subjected to control or
drug treatments was randomized; each experiment
was performed on at least three independent occa-
sions.
Hoechst staining
Cultures were fixed in ice-cold 4% paraformaldehyde
(10 min), washed in phosphate-buffered saline (PBS)
and incubated with Hoechst 33342 (Phenol, 4-[5-(4-
methyl-1-piperazinyl)[2,50-bi-1H-benzimidazol]-20-
yl]-, trihydrochloride) (1 mg/ml; Molecular Probes,
Leiden, The Netherlands) for 45 min in the dark.
After rigorous washing (PBS), coverslips were
mounted in antifading medium. The total number of
cells per unit area was determined by counting all
Hoechst-stained nuclei, that is, those with intact and
disintegrating nuclei, using the cell counting para-
meters described below.
Immunocytochemistry
For characterization of cultures by light microscopy,
cells were fixed in ice-cold 4% paraformaldehyde
(10 min) and incubated with the following primary
antibodies: mouse anti-microtubule-associated pro-
tein 2 (MAP2; Roche, Mannheim, Germany; 2 mg/ml),
mouse anti-myelin basic protein (MBP) for oligoden-
drocytes (Chemicon, Temecula, CA, USA; 1 : 500) and
rabbit anti-glial fibrillary acidic protein (GFAP;
DAKO, Hamburg, Germany; 1 : 500). Peroxidase-con-
jugated antibodies (Sigma) and 3,30-diaminobenzi-
dine tetrahydrochloride (0.025%; Sigma) were used to
visualize immunoreactive elements. Specimens were
examined on an Olympus BX-60 microscope, video-
linked to a computer equipped with image-processing
software (ImagePro, Maryland, USA). Cell counts
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were performed on equally sized microscopic fields
from five coverslips under 400 magnification; 10
fields (0.072 mm2) were randomly chosen across two
diameters of the coverslip in order to avoid potential
confounding errors arising from periphery–center
gradients in the distribution of cells; an average of
1000 cells were sampled on each coverslip, and the
results shown represent values from five to eight
coverslips per treatment. Data representing numbers
of immunolabeled cells are expressed relative to total
number of cells labeled with Hoechst dye (see above).
Electron microscopic analysis
For classical electron microscopic characterization of
the cultures, cells were fixed in 1% paraformalde-
hyde/1% glutaraldehyde in 0.1 M PBS (pH 7.4) for
1 h. Thereafter, the cells were treated with 1%
osmium tetroxide, dehydrated in a graded series of
ethanol and flat-embedded in Epon resin.22 Serial
ultrathin sections were cut on an ultratome and
contrasted with uranyl acetate and Reynold’s lead
citrate. Ultrastructural evaluation was carried out
with a Hitachi transmission electron microscope.
Detection of apoptosis by TUNEL histochemistry
Terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP nick-end labeling (TUNEL) histo-
chemistry was performed on 4% paraformaldehyde-
fixed cells, as described.14,23 TdT was purchased from
MBI Fermentas (Heidelberg, Germany). The above-
detailed morphometric procedures were use to quan-
tify numbers of apoptotic (TUNEL positive) as a
proportion of Hoechst-stained cells.
Reverse-transcriptase PCR
To detect GR and MR mRNA transcripts in the
cultures, total RNA, free from chromosomal DNA
contamination, was isolated (RNAeasy kit, Qiagen,
Hilden, Germany) and reverse transcribed with
SUPERSCRIPTt II RNA H-reverse transcriptase (Life
Technologies) using custom-synthesized oligo-dT12–18
primers (MWG Biotech, Ebersberg, Germany). Pub-
lished primers24 were used and amplication condi-
tions were denaturation for 40 s at 941C, annealing for
1 min at 621C (MR) or 401C (GR), and primer extension
for 2 min at 721C; optimal amplifications of MR and
GR mRNA were achieved after 35 and 25 cycles,
respectively.
Nuclear translocation of MR and GR
After 6 days in vitro, cells were exposed to either DEX
or ALDO (both at 108 M) for 6 h. Cells were then
either prepared for detection of MR and GR by
immunofluorescence (fixation as before) or Western
blotting, using rabbit antiglucocorticoid receptor (GR;
Santa Cruz Biotechnology, Heidelberg, Germany;
1 : 1500) or rabbit antimineralocorticoid receptor
(MR; Santa Cruz; 1 : 1500). Fluorescence images from
DEX- or ALDO-treated cells were visually compared
to those from nontreated cells; in the case of GR, the
abundance of translocated receptor was obvious,
whereas degree of MR occupation had to be based
on subjectively judged increases in fluorescence
signal intensities. For GR Western blots, cells were
lysed, processed and evaluated using semi-quantita-
tive densitometry as described previously.25
Statistics
All numerical data, shown as means7SEM, were
subjected to ANOVA and appropriate post hoc
analyses (SigmaStat 3). The level of significance was
preset at Pr0.05.
Results
Model validation
Studies in various species, including humans, pri-
mates, sub-primates and rats, have described correla-
tions between elevated systemic levels of
corticosteroids levels and reduced hippocampal vo-
lumes and increased hippocampal cell death or
neuritic atrophy.4–14,26 Corticosteroids have also been
shown to increase the likelihood of neuronal death in
rat embryonic hippocampal cultures.27,28 In the pre-
sent experiments, hippocampal cell cultures were
prepared from postnatal rats, aged 4–5 days. Cells
were grown in a serum-free, chemically defined
medium, which contained nanomolar amounts of
cortisol (see Materials and methods). Preliminary in
vivo studies showed that the hippocampi of rats of
this age are sensitive to the apoptosis-inducing
actions of DEX, showing a 60% increase in cell death
following an acute injection of the drug (data not
shown).
Cells established dense networks in vitro, with
some 25–30% of cells staining positively for MAP2, a
marker of mature neurons (Figure 1a and b). GFAP-
positive astrocyctes (Figure 1c) or and myelin basic
protein-positive oligodendrocytes (Figure 1d) made
up some 10–15% of the culture population. Approxi-
mately 40% of cells in culture incorporated the
mitosis marker bromodeoxyuridine, some 30% of
which were found to be neuroblasts (doublecortin
positive).29 Electron microscopic analysis of the
cultures revealed cells showing morphological fea-
tures typical of neurons, astrocytes and oligodendro-
cytes (Figures 1e–j).
Consistent with results from in vivo studies,30,31
cells in culture were seen to express MR and GR
mRNA (detected by RT-PCR analysis; Figure 2a) as
well as receptor protein (immunofluorescence images
in Figures 2b and c). Under basal conditions, MR
were localized in both the cytoplasmic and nuclear
compartments, probably owing to the low levels of
cortisol in the medium supplement (B27) or because
of its apparent ligand-independent localization;32
treatment with ALDO resulted in a greater intensity
of immunoreactive signal in the nucleus. In contrast,
GR in untreated cells were predominantly located in
the cytoplasm, and were only found in the nucleus
after exposure to DEX. The morphological localiza-
tion of GR was corroborated by evidence obtained by
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Western blot analysis of cytoplasmic and nuclear
fractions; Figure 2d shows that DEX treatment results
in a conspicuous relocation of GR from the cytoplas-
mic to the nuclear compartment. Together, these data
indicate that the receptors expressed in vitro are likely
to serve their roles as ligand-activated transcription
factors.
DEX induces neuronal cell death in an ALDO-
reversible manner
Treatment of hippocampal cultures with the GR
agonist DEX (105 M) doubled the relative number of
TUNEL-positive (apoptotic) cells within 48 h
(Po0.05; Figure 3a). A significant proportion of these
apoptotic cells were mature neurons, as judged by the
reduction in the MAP2 immunoreactive subpopula-
tion (Po0.05; Figure 3b). Whereas exposure to ALDO
(105 M) alone did not affect the incidence of
apoptosis or the number of surviving neurons, the
MR agonist significantly attenuated the apoptosis-
inducing actions of DEX (Po0.5; Figure 3). Thus,
consistent with our previous findings,13,14 MR occu-
pation counteracts the actions GR.
MR antagonism causes apoptosis and accentuates GR-
mediated apoptosis
Blockade of MR with SPIRO (108–105 M) resulted in
a dose-dependent increase in levels of apoptosis
(Figure 4a). The less-potent MR antagonist oxprenoate
(RU28318)33–35 only stimulated apoptosis when used
at 105 M, the highest doses tested (Figure 4b). The
apoptotic actions of SPIRO and RU28318 most
probably result from their counteraction of the
prosurvival effects of the nanomolar (MR-activating)
levels of corticosterone in the B27/Neurobasal med-
ium; these results indicate that tonic occupation of
MR is essential for neuronal survival. The view that
MR activation promotes cell survival was boosted by
the finding that both MR antagonists synergized with
a suboptimal dose of DEX (106 M; 10-fold lower than
the dose used in the previous experiment) to induce
apoptosis; our observations show that manifestation
of the full apoptotic potential of GR agonists in vitro
can be masked by MR agonists that are inadvertently
present in the medium.
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Figure 1 Immunocytochemical and ultrastructural char-
acterization of primary postnatal rat hippocampal cultures.
(a) Low-magnification field view of primary rat hippocam-
pal cultures (5 days in vitro), immunostained with MAP2.
(b) High-power micrography showing differentiated MAP2-
immunolabeled neurons. (c) High-power micrograph of
astrocytes immunostained for GFAP. (d) An immunoreac-
tive oligodendrocyte labeled with anti-MBP. Scale bars
represent 120mm (a) and 30 mm (b–d). (e) Medium-power
electron micrograph of a cultured cell showing typical
features of a neuron. Note the large nucleus (Nu) within the
perikaryon (P) richly endowed with free and membrane–
bound ribosomes. ( 10 000). (f) Electron micrograph
showing numerous ribosomes (arrow) and cysts of a Golgi
complex (arrowhead) within the neuronal cytoplasm
( 28 000). (g) Demonstration of a growing neuronal process
(P) exhibiting bundles of microtubules and mitochondria
( 13 000). (h) High-power view of a neuronal process with
microtubules organized in a parallel fashion (arrow). Note
the association of ovoid transit vesicles (arrowheads) with
microtubules ( 32 000). (i) High-power micrograph of an
astrocyte with a prominent bundle of glial filaments within
its cytoplasm (arrows) ( 40 000). (j) Example of a neuronal
perikaryon (P) lying adjacent to a glial process (GP) showing
glial filaments (arrowhead). Also shown is a neuronal
process (NP) growing along the surface of the glial element.
The arrow points to a cluster of synaptic-like vesicles
( 30 000).
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Discussion
While a number of potential molecular mechanisms
may be proposed to explain the basis of impaired GR
feedback in the hippocampus, the impact of GR-
induced destruction of the neural substrate mediating
this feedback has been a recurring theme in psycho-
neuroendocrinology over the last decade. A series of
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Figure 2 GR and MR receptor expression and translocation
in hippocampal cell cultures. (a) RT-PCR demonstration of
MR and GR expression in primary hippocampal cultures
maintained for 5 days in vitro. The transcript size of each
receptor corresponded with previously published data.24 (b)
Low-power photomicrograph showing neurons displaying
GR immunoreactivity. Note that the cells were treated with
DEX (107 M) for 6 h before fixation, and that the GR signal
is mainly located in nuclei, indicating translocation of the
receptor from its normal cytoplasmic (unliganded) location.
(Scale bar represents 60mm). (c) High-power view of a
neuron displaying MR immunoreactivity in its nucleus
following exposure to the prototypic MR agonist ALDO
(108 M) for 6 h (scale bar represents 15 mm). Note that a
small proportion of neurons and glia displayed MR
immunoreactivity in their cytoplasm in the absence of
exogenous ligand (data not shown), probably owing to the
low concentrations of cortisol present in the growing (B27)
medium. (d) Further demonstration (Western blot) that DEX
treatment (106 M) mobilizes immunoreactive GR to the
nucleus. (e) Cells showing some typical features of
apoptosis as revealed by TUNEL histochemistry are in-
dicated by arrows; culture was treated with DEX.
Figure 3 Opposing effects of GR and MR ligands on
hippocampal neuron survival. (a) In contrast, the effects of
the MR agonist ALDO (105 M), the GR ligand DEX (105 M)
induces significant levels of apoptosis in hippocampal
cultures. The apoptotic potential of DEX is significantly
attenuated when cultures are concomitantly treated with
ALDO and DEX. (b) The size of the neuronal (MAP2-
positive) subpopulation of cells in the cultures is signifi-
cantly reduced in the presence of DEX (105 M) and
unaffected by ALDO (105 M); the number of MAP2-positive
neurons is not significantly different from that observed in
controls when cultures are exposed both ALDO and DEX. It
is inferred from the mirror images of the data shown in (a)
and (b) that DEX targets neurons for apoptotic death in an
ALDO-reversible manner.
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in vivo studies in rats previously demonstrated that
the GR agonist DEX stimulates cell death in the
hippocampus as well as in other selected brain
regions such as the striatum and substania ni-
gra.13,14,36,37 However, it remains unclear as to whether
these effects occur directly or whether glucocorticoids
merely exacerbate the neurotoxic effects of other more
potent insults such as excitatory amino acids and
reactive oxygen species.27,28,38
Direct neural actions of DEX have also been
questioned on the basis of data showing that DEX
has limited access to the brain.1 Observations that
adrenalectomy leads to apoptosis in the hippocam-
pus,18,19,39 together with the fact that DEX treatment
leads to a state of ‘chemical adrenalectomy’,1 boost
the argument against direct effects of DEX on
hippocampal cell survival. On the other hand,
significant levels of apoptosis can be observed within
24 h of a single injection of DEX,14 whereas the effects
of adrenalectomy display different temporal and
spatial dynamics.39–41 Further, the apoptotic effects
of DEX were previously shown to be blocked with a
GR antagonist;36 GR are transcription factors and we
have previously shown that their activation by DEX
can trigger a molecular death cascade in the hippo-
campus and cell cycle arrest in a neural cell line.13,25
The issue of whether DEX acts directly on neurons
to stimulate their demise cannot be resolved easily in
vivo. We therefore attempted to address this question
in primary neuronal cultures derived from early
postnatal rats. These cultures were carefully charac-
terized and their suitability for our studies verified,
especially with respect to ontogeny of elements
involved in the regulation and responsiveness of the
HPA axis,30,31,42 as well as to age-related differences in
the in vivo responses to the cell death-inducing
actions of corticosteroids.14,43 The majority of mature
neurons (MAP2 immunoreactive) cells in culture
displayed the typical size and shape of granule cells.
Although immature neurons (doublecortin-positive)
cells were also observed, our analysis only included
cells staining for MAP2 since previous studies
showed that newly born hippocampal cells do not
express MR and GR.44
The exposure of cultures to DEX at a dose of 105 M
led to a significant loss of mature (MAP2-positive)
neurons, an event accompanied by a significant
increase in the incidence of apoptosis. The results
obtained in this isolated hippocampal neuron model,
in which DEX can directly access individual cells,
therefore show that DEX has the intrinsic potential to
induce neuronal cell death, and that its effects occur
independently of the HPA axis and other confounding
factors. The results of previous studies have shown
that DEX induces apoptosis by activating GR:36
although some earlier reports have suggested that
DEX may bind to MR under specific in vitro
conditions, there is strong evidence that DEX is
predominantly a GR agonist.45
The apoptotic actions of DEX (105 M) were shown
to be significantly attenuated when the MR agonist
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Figure 4 Blockade of MR compromises neuronal survival
and predisposes neurons to DEX-induced apoptosis. As
compared to the previously used dose of DEX (105 M;
Figure 3), a 10-fold lower dose of the GR agonist does not
cause significant apoptosis in hippocampal cultures (cf
second and third bars in a and b). Reasoning that this may
have resulted from nanomolar (MR-activating) concentra-
tions of levels of corticosterone in the culture medium, cells
were exposed to two MR antagonists, SPIRO (a) and
RU28318 (b); these compounds display slightly different
pharmacological profiles.33–35 In the absence of DEX,
addition of SPIRO (108–105 M) dose dependently in-
creased the incidence of apoptosis (a); RU28318 at a dose
of 105 M also significantly stimulated apoptosis (b). In
combination with the apoptosis noninducing dose of DEX
(106 M; a and b), all doses of SPIRO and RU28318 led to
levels of cell death that were significantly greater than those
seen after treatment with the antagonist alone, that is,
blockade of MR with either SPIRO or RU28318 increased
neuronal sensitivity to the apoptotic actions of DEX.
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ALDO (105 M) was added to the culture medium.
This finding is consistent with previous results
obtained in rats.11,13,14 Since ALDO on its own did
not alter apoptotic cell and neuronal numbers, our
results add currency to the view that MR can trigger
neuroprotective mechanisms; the latter concept
emerged from a number of older studies, which
showed that either ALDO or low, MR-activating levels
of corticosterone could prevent or reverse adrenalect-
omy-induced apoptosis.46,18,41 Notably, the effects of
adrenalectomy cannot be ameliorated by the admin-
istration of DEX.19,47
Chemically defined, serum-free media of the sort
used in these studies have significant advantages over
serum-containing media. Nevertheless, our experi-
ments were somewhat confounded by the presence of
corticosterone (nanomolar range, sufficient to activate
MR) in the medium. This factor most probably
accounts for our observation that the MR antagonist
SPIRO increased neuronal cell death in a dose-
dependent (107–105 M) manner, although another
(weaker) MR antagonist (RU28318) did not alter basal
levels of apoptosis. This finding supports the inter-
pretation that tonic activation of MR is essential for
the survival of hippocampal neurons.
In view of the above results, we hypothesized that
blockade of ‘medium-activated’ MR would accentuate
the effects of GR stimulation; the hypothesis was
proven correct by analysis of apoptosis after con-
comitantly treating cultures with either SPIRO or DEX
and a suboptimal dose of DEX: whereas DEX at a dose
of 106 M did not induce cell death, its combination
with a range of doses of SPIRO or RU28318 (108–
105 M) significantly exacerbated the occurrence of
neuronal apoptosis. Besides acting on MR, SPIRO can
also antagonize androgen and progesterone recep-
tors;48 however, since similar results were obtained
with RU28318, a drug with greater selectivity for MR,
our inference that neuroprotective effects are
mediated by MR is warranted.
In summary, evidence gained in a cellular model
shows that GRs can lead to hippocampal cell death
without the participation of other aggravating factors,
so long as their effects are not masked by previously
activated MR. The presented results also bolster the
view that hippocampal neuronal survival depends on
the tonic occupation of MR. Further, insofar that these
data demonstrate the opposing roles of MR and GR in
hippocampal cell survival, they add credibility to the
‘receptor balance hypothesis’ that was generated from
endocrinological and behavioral studies.1,17 If GR-
induced hippocampal cell losses do indeed contri-
bute to impaired regulation of the HPA axis, even-
tually leading to mood, anxiety and cognitive
impairments, therapeutic tools designed to activate
selectively MR or to improve specifically their
signaling efficiency in neurons49,50 would be a
worthwhile strategy. In closing, it however needs to
be emphasized that, even if deserving of further
investigation with respect to functional significance,
the contribution of apoptotic events to hypercortiso-
lemia-induced reductions in hippocampal size are
unlikely to be major; as discussed elsewhere,12 the
fact that recovery of both the morphological and
behavioral changes caused by elevated corticosteroid
secretion are possible after nomocortisolemia has
been re-established,8,51 suggesting that the reported
reductions in hippocampal volume are partially due
to neuritic atrophy rather than irreversible cell death.
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